Abstract:【Objective】To evaluate the predictive value of urine α-1 microglobulin (α1-MG) level for preeclampsia (PE) during gestational rats.【Methods】A total of 26 female SD rats under SPF condition were confirmed to be pregnant. These SD female rats were randomly divided into the PE model group and the normal pregnancy group, with 13 in each group. From the 11th day of pregnancy, rats in PE model group received Angiotensin Ⅱ-type 1 receptor antagonist (AT1-AA) while mice in normal pregnancy group received equal volume of saline by tail vein injection for 7 days. The tail artery systolic pressure was measured by animal's noninvasive blood pressure tester from the 10th day of pregnancy. The urine of pregnant rats of the two groups was collected on the 8th, 12th, 16th, and 20th day of pregnancy. The concentration of urine α1-MG in the two groups was detected by rate immunoassay. Caesarean section was performed before pregnancy end. The average number of newborn rats, the rate of deformity and stillbirth rate were compared between the two groups. The weight of newborn rats and wet weight of placenta were measured.【Results】At 12 to 21 days of gestation, the systolic blood pressure of the tail artery in the PE model group was significantly higher than that of the normal pregnancy group (P<0.05). The systolic pressure of the tail artery in the PE model group increased significantly from the 12th to the 18th day of gestation, and there was a statistically significant difference between the two adjacent days (P<0.05). The level of α1-MG in urine of d12, d16and d20during the gestational period was significantly higher in the PE model group than in the normal pregnancy group (P<0.05). The difference between the urinary α1-MG levels in the PE model group was statistically significant (P<0.05). The average number and weight of newborn rats and wet weight of placenta in PE model group were significantly lower than those in the normal pregnancy group (P<0.05). The deformity rate and stillbirth rate in the PE model group were significantly higher than those in the normal pregnancy group (P<0.05).【Conclusion】Pregnancy hypertension, higher levels of urinary α1-MG, and poor quality of newborn rats are observed in the AT1-AA induced PE rat model. So, it is speculated that the detection of urine α1-MG level has important predictive value for preeclampsia in rats.
刘瑀晗,包南丁,张越,张艳宁. 尿α1微球蛋白对妊娠期大鼠子痫前期的预测价值[J]. 医学临床研究, 2018, 35(3): 441-444.
LIU Yu-han, BAO Nan-ding, ZHANG Yue, et al. Urine α-1 Microglobulin Level in Prediction of Preeclampsia in Pregnant Rats. JOURNAL OF CLINICAL RESEARCH, 2018, 35(3): 441-444.
[1] 杨孜.子痫前期综合征胎盘介导相关因素预警、早期发现及临床处理选项[J].中国实用妇科与产科杂志,2016,32(4):302-308. [2] 柳相珍,张媛,徐成伟,等.子痫前期患者血浆中可溶性内皮细胞蛋白C受体与血管性血友病因子及可溶性血栓调节蛋白的水平变化[J].中华检验医学杂志,2016,39(10):783-785. [3] 肖传宇,侯文华,陶峰,等.联合检测血清β2-微球蛋白和胱抑素C对高血压肾病的诊断意义[J].中国实验诊断学,2017,21(4):645-646. [4] 程爱花.血清视黄醇结合蛋白和尿α1-微球蛋白在妊娠糖尿病早期肾损害诊断中的应用价值[J].中国优生与遗传杂志,2016,45(9):47-48. [5] Brosnihan KB,Dechend HR.Increased angiotensin ii in the mesometrial triangle of a transgenic rat model of preeclampsia [J].Hypertension,2010,55(2):562-566. [6] 吕连峥,蔺昕,钱雷,等.子痫前期患者外周血单核细胞Toll样受体4检测及其意义[J].现代生物医学进展,2015,15(35):6952-6955. [7] 张洋,肖庆飞,赵永利,等.糖尿病患者尿中nephrin蛋白的表达及临床意义[J].中国实验诊断学,2017,21(9):1566-1568. [8] Anderson UD,Gram M,Ranstam J,et al.Fetal hemoglobin,α1-microglobulin and hemopexin are potential predictive first trimester biomarkers for preeclampsia [J].Pregnancy Hypertens,2016,6(2):103-109. [9] 周晶,严国锋,罗章源,等.子痫前期大鼠模型建立及相关指标监测[J].实验动物与比较医学,2015,35(6):448-452. [10] 李瑜,王光花,曹志娟,等.妊娠期高血压及子痫前期对妊娠及新生儿结局的影响研究[J].中国儿童保健杂志,2016,24(5):458-461. [11] Erlandsson L,Nv ,Hennessy A,et al.Inventory of novel animal models addressing etiology of preeclampsia in the development of new therapeutic/intervention opportunities [J].Am J Reprod Immunol,2016,75(3):402-405. [12] 柳宛璐,乔福元,刘海意,等.Synaptopodin参与低分子肝素改善子痫前期大鼠蛋白尿的机制研究[J].现代妇产科进展,2015,16(4):283-286. [13] 宋文炜.血清胱抑素C联合β2-微球蛋白检测对妊娠期糖尿病早期肾损伤的临床价值研究 [J].国际检验医学杂志,2016,37(22):3134-3136. [14] 黄杏红,邵懿,罗正春.硫酸镁与硝苯地平联合丹参治疗对子痫前期患者胎盘血流灌注及氧化应激、细胞凋亡的影响[J].海南医学院学报,2017,23(10):1373-1376. [15] 耿辉,魏雁虹,宋帅,等.α1-微球蛋白、C-反应蛋白、D-二聚体联合检验在妊娠期高血压疾病诊疗中的意义[J].中国妇幼保健,2017,32(9):1847-1849. [16] 徐鑫,杨星宇,何碧薇,等.TLR9激动剂诱导建立小鼠子痫前期动物模型的研究[J].现代妇产科进展,2015,42(4):266-268. [17] 赵虎,张凌,蔡一玲,等.妊娠期高血压疾病患者胎盘组织中VEGF与MMP-9表达水平与子痫前期病情的相关性[J].实用临床医药杂志,2016,20(15):63-65.